Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 39.2M | 33.9M | 36.6M | 35.0M |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 14.2M | 15.2M | 14.1M | 13.7M |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 8.1M | 5.2M | 11.5M | 10.9M |
Tax provision | 1.8M | 752K | 2.6M | 2.3M |
Net income | 6.3M | 4.5M | 9.0M | 8.6M |
Basic EPS | 0.4 | 0.3 | 0.5 | 0.5 |
Diluted EPS | 0.4 | 0.3 | 0.5 | 0.5 |
Basic average shares | 18.7M | 18.8M | 18.7M | 18.7M |
Diluted average shares | 18.7M | 18.8M | 18.8M | 18.7M |
EBITDA | — | — | — | — |
Net income from continuing op. | 6.3M | 4.5M | 9.0M | 8.6M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |